1. Home
  2. EXAS vs AGCO Comparison

EXAS vs AGCO Comparison

Compare EXAS & AGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • AGCO
  • Stock Information
  • Founded
  • EXAS 1995
  • AGCO 1990
  • Country
  • EXAS United States
  • AGCO United States
  • Employees
  • EXAS N/A
  • AGCO N/A
  • Industry
  • EXAS Medical Specialities
  • AGCO Industrial Machinery/Components
  • Sector
  • EXAS Health Care
  • AGCO Industrials
  • Exchange
  • EXAS Nasdaq
  • AGCO Nasdaq
  • Market Cap
  • EXAS 9.1B
  • AGCO 7.5B
  • IPO Year
  • EXAS N/A
  • AGCO 1992
  • Fundamental
  • Price
  • EXAS $45.60
  • AGCO $112.24
  • Analyst Decision
  • EXAS Strong Buy
  • AGCO Buy
  • Analyst Count
  • EXAS 22
  • AGCO 9
  • Target Price
  • EXAS $66.43
  • AGCO $110.89
  • AVG Volume (30 Days)
  • EXAS 3.9M
  • AGCO 958.4K
  • Earning Date
  • EXAS 08-06-2025
  • AGCO 07-31-2025
  • Dividend Yield
  • EXAS N/A
  • AGCO 3.26%
  • EPS Growth
  • EXAS N/A
  • AGCO N/A
  • EPS
  • EXAS N/A
  • AGCO 1.34
  • Revenue
  • EXAS $2,939,949,000.00
  • AGCO $10,172,100,000.00
  • Revenue This Year
  • EXAS $14.61
  • AGCO N/A
  • Revenue Next Year
  • EXAS $12.71
  • AGCO $4.72
  • P/E Ratio
  • EXAS N/A
  • AGCO $84.08
  • Revenue Growth
  • EXAS 12.55
  • AGCO N/A
  • 52 Week Low
  • EXAS $38.81
  • AGCO $73.79
  • 52 Week High
  • EXAS $72.83
  • AGCO $121.16
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 44.47
  • AGCO 53.21
  • Support Level
  • EXAS $40.55
  • AGCO $108.23
  • Resistance Level
  • EXAS $45.45
  • AGCO $115.59
  • Average True Range (ATR)
  • EXAS 2.04
  • AGCO 3.81
  • MACD
  • EXAS 0.07
  • AGCO -0.25
  • Stochastic Oscillator
  • EXAS 63.10
  • AGCO 42.90

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About AGCO AGCO Corporation

Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealer and distribution locations and reach into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its unconsolidated joint venture with Rabobank of the Netherlands.

Share on Social Networks: